Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 39,703 | 29,924 | 25,073 | 15,381 | 10,526 |
| Operating Income | -39,703 | -29,924 | -25,073 | -15,381 | -10,526 |
| Interest Expense | 0 | 0 | 0 | 0 | 64 |
| Other Income | 3,579 | 3,199 | 1,108 | 545 | 133 |
| Pre-tax Income | -36,124 | -26,725 | -23,964 | -14,836 | -10,457 |
| Net Income Continuous | -36,124 | -26,725 | -23,964 | -14,836 | -10,457 |
| Net Income | $-36,124 | $-26,725 | $-23,964 | $-14,836 | $-10,457 |
| EPS Basic Total Ops | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
| EPS Basic Continuous Ops | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
| EPS Diluted Total Ops | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
| EPS Diluted Continuous Ops | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.46 | -1.50 | -0.93 | -3.69 |
| EBITDA(a) | $-39,686 | $-29,913 | $-25,061 | $-15,372 | $-10,526 |